Results 1 - 20 of 31,215 for All Library Resources
Sorted by:
Sorted by:
PopularityOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Newsletter Article
|
|
What is cardiomyopathy?Harvard Heart Letter, 2018COPYRIGHT 2018 Harvard Health Publishing ;COPYRIGHT 2018 All Rights Reserved. ;Copyright © 2018 by Harvard University. All rights reserved. ;ISSN: 1051-5313 ;EISSN: 1943-510XFull text available |
| 2 |
Material Type: Newsletter Article
|
|
‘Easygoing’ mother’s shock at stress-induced broken-heart syndrome diagnosisPress Association, 2024Copyright Press Association Limited Jan 11, 2024Digital Resources/Online E-Resources |
| 3 |
Material Type: Newsletter Article
|
|
4D Molecular Discloses Updated Data From Currently Paused Fabry Disease Cardiomyopathy StudyBenzinga Newswires, 20232020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
| 4 |
Material Type: Newsletter Article
|
|
LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese PatientsBenzinga Newswires, 20232020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
| 5 |
Material Type: Newsletter Article
|
|
Clinical Trial: Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic CardiomyopathyUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Apr 8, 2024Digital Resources/Online E-Resources |
| 6 |
Material Type: Newsletter Article
|
|
Bristol Myers' Mavacamten Shows Sustained Improvements In Cardiovascular Outcomes In Cardiomyopathy StudyBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
| 7 |
Material Type: Newsletter Article
|
|
BridgeBio Pharma Highlights Mid-Stage Study Data Of Acoramidis In Cardiomyopathy TrialBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
| 8 |
Material Type: Newsletter Article
|
|
Bristol Myers Squibb's Mavacamten Aces Late-Stage Trial In CardiomyopathyBenzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
| 9 |
Material Type: Newsletter Article
|
|
Cardiomyopathy, one of the most common diseases in Spain: symptoms and how to prevent sudden deathCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
| 10 |
Material Type: Newsletter Article
|
|
Andrés Román's gesture that is an example of resilience and professionalism at NacionalCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
| 11 |
Material Type: Newsletter Article
|
|
Clinical Trial: Microvascular Dysfunction Assessment to Predict Left Ventricular Reverse RemodelingUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Apr 10, 2024Digital Resources/Online E-Resources |
| 12 |
Material Type: Newsletter Article
|
|
Andrés Felipe Román doubts whether he will remain at Millonarios: the issue of his contract renewal is still in questionCE Noticias Financieras, 2022CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
| 13 |
Material Type: Newsletter Article
|
|
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out? -- IBDDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Mar 4, 2024Digital Resources/Online E-Resources |
| 14 |
Material Type: Newsletter Article
|
|
Are you under 35 years old? This is the leading cause of sudden deathCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
| 15 |
Material Type: Newsletter Article
|
|
Bristol Myers Squibb Announces Topline Results From Phase 3 VALOR-HCM Trial; Study Met Primary Endpoint At Week 16Benzinga Newswires, 20222020 Benzinga.com - Benzinga does not provide investment advice. All rights reserved.Digital Resources/Online E-Resources |
| 16 |
Material Type: Newsletter Article
|
|
Cytokinetics Announces New Data From FOREST-HCM to be Presented at CMR 2024News Bites - Healthcare & Equipment, 2024Copyright News Bites Pty Ltd Jan 19, 2024Digital Resources/Online E-Resources |
| 17 |
Material Type: Newsletter Article
|
|
BridgeBio Pharma Reports Positive Phase 3 Data for Cardiomyopathy Drug TrialDow Jones Institutional News, 2023Copyright Dow Jones & Company Inc. Jul 17, 2023Digital Resources/Online E-Resources |
| 18 |
Material Type: Newsletter Article
|
|
Cardiovascular Imaging Journal Issues Research Articles in Nov. 1, 2023 EditionTargeted News Service, 2023Targeted News ServiceDigital Resources/Online E-Resources |
| 19 |
Material Type: Newsletter Article
|
|
Millonarios president rules out lawsuit against Boca Juniors for Andrés Felipe RománCE Noticias Financieras, 2021CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
| 20 |
Material Type: Newsletter Article
|
|
Clinical Trial: Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable WayUS Fed News Service, Including US State News, 2023Copyright HT Digital Streams Limited May 10, 2023Digital Resources/Online E-Resources |
Results 1 - 20 of 31,215 for All Library Resources
Sorted by:
Sorted by:
PopularityOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 2017 (1,034)
- 2017 To 2018 (3,096)
- 2019 To 2020 (6,602)
- 2021 To 2023 (16,752)
- After 2023 (3,732)
-
More options
New Records
- New From Last Week (17)
- New From Last Month (658)
- New From Last 3 Month (2,308)
-
More options
Subject
- Cardiomyopathy (8,127)
- Clinical Trials (7,615)
- Stockholders (6,605)
- Earnings Per Share (5,925)
- Biotechnology Industry (4,776)
- Heart Failure (4,302)
- Patients (3,944)
- Net Losses (3,842)
- R&d (3,556)
- Research & Development (3,556)
- Investments (3,456)
- Webcasting (3,275)
- Corporate Profits (3,021)
- Stock Exchanges (2,914)
- Collaboration (2,854)
- Cardiovascular Disease (2,723)
- Fda Approval (2,639)
- Disease (2,618)
- Heart (2,349)
- Covid-19 (2,334)
-
More options
Databases
- ProQuest Central (31,214)
- MEDLINE (1)
-
More options
Language
- English (31,200)
- Spanish (6)
- German (5)
- French (3)
- Arabic (3)
- Urdu (1)
- Portuguese (1)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||